Faculty
 |
|
Jerrie Gavalchin, Ph.D.
Professor, Medicine
1244 Weiskotten Hall Upstate Medical University 750 East Adams Street Syracuse, NY 13210
(315) 464-5446
| Education and Clinical Training
Ph.D.: 1983, Rutgers University
Postdoctoral Fellow: Tufts University School of Medicine
Clinical Department/Section Affiliations
Medicine/Infectious Diseases
Research Program and Department Affiliations
Biomedical Sciences Program
Medicine
Research Interests Regulation of pathogenic antibody production in autoimmune glomerulonephritis; Cell-surface receptors for retroviruses
Research Abstract
Pathogenetic Mechanisms in Systemic Lupus Erythematosus (SLE)
Females of the F1 cross between NZB and SWR mice develop a severe and
accelerated glomerulonephritis, very similar to human SLE, and we are using this model to
understand the pathogenetic mechanisms involved in the disease. Our hypothesis is that
dysregulation of the production of immunoglobulins which are deposited in the kidneys and
bear a unique marker, IdLNF1, is critical to disease development. T
cell clones that react with a peptide which encodes this marker, accelerate disease, and,
conversely, antibodies which react with this marker downregulate production of IdLNF1-expressing
antibodies, leading to increased survival. Finally, vaccination of mice with this peptide
early in life, before disease onset, leads to significantly longer survival. These studies
suggest that it may be possible to develop therapeutic approaches that target specific
pathogenic cells in SLE. They may also further our understanding of the role of female sex
hormones in disease.
Characterization of the HTLV-I Receptor. With B. Poiesz, M. Lane
HTLV-I is believed to be the etiologic agent of adult T-cell leukemia (ATL) and
Tropical Spastic Paraparesis (TSP) Binding of the virus to a specific cell surface
molecule that is expressed on a wide variety of cell types appears to mediate infection.
We have derived a monoclonal antibody which blocks binding of the virus to its receptor
and infection of susceptible cells. We are currently using this antibody to isolate the
gene encoding this molecule, and will characterize its product. These studies will
contribute information critical to understanding the pathogenesis of HTLV-I diseases, and
aid in the development of new approaches for their treatment.
Selected References
Gavalchin, J., Fan, N., Waterbury, P.G., Corbett, E., Faldasz, B.D., Peshick, S.M.,
Poiesz, B.J., Papsidero, L., and Lane, M.J. (1995) Regional localization of the putative
cell surface receptor for HTLV-q to human chromosome 17q23.2-17q25.3. Virology
212:196-203.
Knupp, C. J., Uner, A.H., Tatum, A.H., Kakanar, J.R. and Gavalchin, J. (1995) IdLNF1-specific
T cell clones accelerate the production of IdLNF1+ IgG and nephritis
in SNF1 mice. J. Autoimmunity 8: 367-380.
Uner, A., Tatum, A.H. Knupp, C. J. and Gavalchin, J. (1998) Characteristics of auto
anti-idiotypic antibodies reactive with antibodies expressing the pathogenic idiotype, IdLNF1,
in the (NZB x SWR)F1 model for lupus nephritis and its parental strains. In
press, J. Autoimmunity.
Dudek, K., Knupp, C.J., Tatum, A.H., Stoll, M. and Gavalchin, J. (1998) Identification
of pathogenic IdLNF1 autoantibody idiotypes derived from the (NZB x
SWR)F1 model for systemic lupus erythematosus. In press, J. Autoimmunity.
Publications - link to PubMed
Note: The above PubMed link opens a new window. Close the PubMed window to
return to this page.
This profile was last updated on 05/15/2009
A short link is available for this profile: http://www.upstate.edu/microb/faculty.php?ID=gavalchj
Return to Faculty List
|